HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation

TSX-V:HME • CA4236301020

Current stock price

2.75 CAD
+0.05 (+1.85%)
Last:

This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. HME.CA Profitability Analysis

1.1 Basic Checks

  • HME had positive earnings in the past year.
  • In the past year HME had a positive cash flow from operations.
  • HME had positive earnings in 4 of the past 5 years.
  • In the past 5 years HME always reported a positive cash flow from operatings.
HME.CA Yearly Net Income VS EBIT VS OCF VS FCFHME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • HME has a Return On Assets of 24.66%. This is amongst the best in the industry. HME outperforms 98.04% of its industry peers.
  • HME has a better Return On Equity (38.33%) than 99.02% of its industry peers.
  • The Return On Invested Capital of HME (31.98%) is better than 99.51% of its industry peers.
  • HME had an Average Return On Invested Capital over the past 3 years of 38.31%. This is significantly above the industry average of 6.85%.
  • The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROIC 31.98%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
HME.CA Yearly ROA, ROE, ROICHME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • HME has a Profit Margin of 30.81%. This is amongst the best in the industry. HME outperforms 95.10% of its industry peers.
  • In the last couple of years the Profit Margin of HME has grown nicely.
  • The Operating Margin of HME (42.73%) is better than 92.16% of its industry peers.
  • In the last couple of years the Operating Margin of HME has grown nicely.
  • HME has a better Gross Margin (60.82%) than 77.94% of its industry peers.
  • In the last couple of years the Gross Margin of HME has remained more or less at the same level.
Industry RankSector Rank
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
HME.CA Yearly Profit, Operating, Gross MarginsHME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. HME.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
  • HME has less shares outstanding than it did 1 year ago.
  • HME has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HME has an improved debt to assets ratio.
HME.CA Yearly Shares OutstandingHME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HME.CA Yearly Total Debt VS Total AssetsHME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • HME has an Altman-Z score of 5.79. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
  • HME's Altman-Z score of 5.79 is amongst the best of the industry. HME outperforms 85.78% of its industry peers.
  • The Debt to FCF ratio of HME is 0.07, which is an excellent value as it means it would take HME, only 0.07 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.07, HME belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
  • HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • HME's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HME outperforms 76.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Altman-Z 5.79
ROIC/WACC4.02
WACC7.96%
HME.CA Yearly LT Debt VS Equity VS FCFHME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.41, HME is in the better half of the industry, outperforming 71.08% of the companies in the same industry.
  • A Quick Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
  • The Quick ratio of HME (1.41) is better than 71.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
HME.CA Yearly Current Assets VS Current LiabilitesHME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HME.CA Growth Analysis

3.1 Past

  • HME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.09%.
  • HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
  • HME shows a decrease in Revenue. In the last year, the revenue decreased by -0.77%.
  • The Revenue has been growing by 25.97% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%

3.2 Future

  • Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
  • Based on estimates for the next years, HME will show a decrease in Revenue. The Revenue will decrease by -7.01% on average per year.
EPS Next Y-9.48%
EPS Next 2Y-11.67%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue Next Year-6.03%
Revenue Next 2Y-7.66%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HME.CA Yearly Revenue VS EstimatesHME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
HME.CA Yearly EPS VS EstimatesHME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

7

4. HME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.17, which indicates a very decent valuation of HME.
  • Based on the Price/Earnings ratio, HME is valued cheaper than 80.39% of the companies in the same industry.
  • HME is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • HME is valuated reasonably with a Price/Forward Earnings ratio of 10.68.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 74.51% of the companies listed in the same industry.
  • HME is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.17
Fwd PE 10.68
HME.CA Price Earnings VS Forward Price EarningsHME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HME is valued cheaper than 90.69% of the companies in the same industry.
  • 95.59% of the companies in the same industry are more expensive than HME, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.93
EV/EBITDA 4.43
HME.CA Per share dataHME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The excellent profitability rating of HME may justify a higher PE ratio.
  • A cheap valuation may be justified as HME's earnings are expected to decrease with -6.72% in the coming years.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2Y-11.67%
EPS Next 3Y-6.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. HME.CA Dividend Analysis

5.1 Amount

  • HME has a Yearly Dividend Yield of 3.68%. Purely for dividend investing, there may be better candidates out there.
  • HME's Dividend Yield is a higher than the industry average which is at 4.63.
  • Compared to an average S&P500 Dividend Yield of 1.82, HME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

  • HME has been paying a dividend for over 5 years, so it has already some track record.
  • HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
HME.CA Yearly Dividends per shareHME.CA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-11.67%
EPS Next 3Y-6.72%
HME.CA Yearly Income VS Free CF VS DividendHME.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
HME.CA Dividend Payout.HME.CA Dividend Payout, showing the Payout Ratio.HME.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HME.CA Fundamentals: All Metrics, Ratios and Statistics

HEMISPHERE ENERGY CORP

TSX-V:HME (4/15/2026, 7:00:00 PM)

2.75

+0.05 (+1.85%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25
Earnings (Next)04-15
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap259.00M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84.44
Price Target2.96 (7.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)20%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)3.57%
EPS NY rev (3m)5.45%
Revenue NQ rev (1m)2.45%
Revenue NQ rev (3m)2.29%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 9.17
Fwd PE 10.68
P/S 2.64
P/FCF 5.93
P/OCF 4.66
P/B 3.28
P/tB 3.28
EV/EBITDA 4.43
EPS(TTM)0.3
EY10.91%
EPS(NY)0.26
Fwd EY9.36%
FCF(TTM)0.46
FCFY16.87%
OCF(TTM)0.59
OCFY21.46%
SpS1.04
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)0.11
Graham Number2.37888 (-13.5%)
Profitability
Industry RankSector Rank
ROA 24.66%
ROE 38.33%
ROCE 42.48%
ROIC 31.98%
ROICexc 43.34%
ROICexgc 43.34%
OM 42.73%
PM (TTM) 30.81%
GM 60.82%
FCFM 44.47%
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 105.19%
Cap/Sales 12.1%
Interest Coverage 250
Cash Conversion 104.31%
Profit Quality 144.34%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 5.79
F-Score6
WACC7.96%
ROIC/WACC4.02
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-9.48%
EPS Next 2Y-11.67%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-6.03%
Revenue Next 2Y-7.66%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%

HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.


What is the valuation status for HME stock?

ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.


What is the profitability of HME stock?

HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.


Can you provide the financial health for HME stock?

The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.


What is the earnings growth outlook for HEMISPHERE ENERGY CORP?

The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -9.48% in the next year.